Optaflexx Plus Rumensin is a drug owned by ELANCO US INC. It is protected by 1 US drug patent filed in 2014. All patents have expired. Details of Optaflexx Plus Rumensin’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US5631298 | Active | |
About Optaflexx Plus Rumensin
Optaflexx Plus Rumensin is a drug
owned by ELANCO US INC.
Optaflexx Plus Rumensin uses
Monensin, Ractopamine Hydrochloride as the active
ingredients.
Active Ingredient:
Optaflexx Plus Rumensin uses
Monensin,
Ractopamine Hydrochloride
as the active ingredients.
Check out other Drugs and Companies using
Monensin, Ractopamine Hydrochloride ingredient.